In line with these findings, antigen-specific CD4+ T cell profiling of acute and convalescent COVID-19 patients indicated that circulating T follicular helper cells play a role in reduced disease severity, further proving that antibody promotion of CD4+ clearance is important [59]. The gene discussed is CD4; the disease is COVID-19.